52-week price history of ELAB Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Elevai Labs Inc.’s current trading price is -97.67% away from its 52-week high, while its distance from the 52-week low is 26.76%. The stock’s price range during this period has spanned from $0.08 to $4.24. In the Healthcare sector, the Elevai Labs Inc.’s shares surpassed a trading volume of approximately 21.07 million for the day, which was noticeably lower compared to the average daily volume of 9.22.44 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Elevai Labs Inc. (ELAB) has experienced a quarterly decline of -77.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.06M and boasts a workforce of 18 employees.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3450, with a change in price of -0.5520. Similarly, Elevai Labs Inc. recorded 14,819,378 in trading volume during the last 100 days, posting a change of -84.79%.
Examining ELAB’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ELAB stands at 0.05. Similarly, the long-term debt-to-equity ratio is also 0.00.
ELAB Stock Stochastic Average
Today, Elevai Labs Inc.’s raw stochastic average for the past 50 days stands at 6.70%, indicating a decline from the raw stochastic average of the last 20 days, which was 19.74%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 18.51% and 19.53% respectively.
ELAB Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -94.58%. However, over the past six months, we’ve seen a stronger performance of -86.04%. The price of ELAB fallen by 7.26% over the last 30 days. And in the last five days, it has fallen by 0.00%.
